Replies to post #1973 on Can Fite BioPharma Ltd (CANF)

[midastouch017]

Revenues for the year ended December 31, 2022 were $0.81 million

[Pitiful revenues, hardly worth mentioning].

As of December 31, 2022, Can-Fite had cash, cash equivalents, and short-term deposits of $7.97 million as compared to $18.90 million at December 31, 2021. The decrease in cash during the year ended December 31, 2022 is due to Company’s operating activity. During January 2023, the Company raised approximately $6.80 million net.

[In other words an additional raise to be expected soon]